F&V Capital Management, LLC Amgen Inc Transaction History

F&V Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 08, 2021	SELL	$221.91 - $258.6 $5.98 Million - $6.97 Million	-26,970 Closed	0 $0
Q4 2020 Jan 11, 2021	BUY	$216.38 - $257.67 $18,392 - $21,901	85 Added 0.32%	26,970 $6.2 Million
Q3 2020 Oct 09, 2020	SELL	$234.65 - $260.95 $140,790 - $156,570	-600 Reduced 2.18%	26,885 $6.83 Million
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $129,565 - $158,994	-655 Reduced 2.33%	27,485 $6.48 Million
Q1 2020 Apr 07, 2020	BUY	$182.24 - $241.7 $163,833 - $217,288	899 Added 3.3%	28,140 $5.71 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $115,418 - $148,352	-610 Reduced 2.19%	27,241 $6.57 Million
Q3 2019 Oct 07, 2019	SELL	$174.11 - $208.62 $27,857 - $33,379	-160 Reduced 0.57%	27,851 $5.39 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $8,335 - $9,770	50 Added 0.18%	28,011 $5.16 Million
Q1 2019 Apr 08, 2019	SELL	$180.87 - $203.88 $289,392 - $326,208	-1,600 Reduced 5.41%	27,961 $5.31 Million
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $8,920 - $10,412	-50 Reduced 0.17%	29,561 $5.76 Million
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $25,014 - $28,200	135 Added 0.46%	29,611 $6.14 Million
Q2 2018 Jul 17, 2018	SELL	$166.05 - $186.51 $312,672 - $351,198	-1,883 Reduced 6.0%	29,476 $5.44 Million
Q1 2018 Apr 16, 2018	BUY	$169.43 - $198.0 $86,917 - $101,574	513 Added 1.66%	31,359 $5.35 Million
Q4 2017 Jan 10, 2018	BUY	$168.79 - $188.59 $39,665 - $44,318	235 Added 0.77%	30,846 $5.36 Million
Q3 2017 Oct 10, 2017	BUY	$167.29 - $191.0 $5.12 Million - $5.85 Million	30,611	30,611 $5.71 Million

3,052

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $174B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of F&V Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on F&V Capital Management, LLC with notifications on news.